Alliqua BioMedical, Inc. Business Finance Contracts & Agreements
124 Contracts & Agreements
- Assignment Agreements (1 contract)
- Credit Agreements (5)
- Escrow Agreements (1)
- Exchange Agreements (2)
- Forbearance Agreements (4)
- Loan Agreements (4)
- Note Agreements (19)
- Purchase Agreements (17)
- Registration Rights Agreements (5)
- Release Agreements (2)
- Repurchase Agreements (1)
- Security Agreements (1)
- Stock Agreements (31)
- Subscription Agreements (1)
- Term Sheets (1)
- Underwriting Agreements (2)
- Warrant Agreements (27)
- Loan and Security Agreement, dated as of November 24, 2015 and as amended from time to time, including by the tenth amendment, by and among Adynxx, Inc. and Oxford Finance LLC (Filed With SEC on November 8, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on November 8, 2019)
- Form of Placement Agent Warrant (Filed With SEC on November 8, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on October 11, 2019)
- Form of Common Warrant (Filed With SEC on October 11, 2019)
- Loan and Security Agreement, dated as of November 24, 2015 and as amended from time to time, including by the ninth amendment, by and among Adynxx, Inc. and Oxford Finance LLC (Filed With SEC on August 22, 2019)
- Form of Pre-funded Warrant (Filed With SEC on August 22, 2019)
- Form of convertible promissory note issued to Domain Partners (Filed With SEC on August 14, 2019)
- Loan and Security Agreement, dated as of November 24, 2015 and as amended from time to time, by and among Adynxx, Inc. and Oxford Finance LLC (Filed With SEC on May 9, 2019)
- Form of warrant issued to Oxford Finance LLC, dated May 3, 2019 (Filed With SEC on May 9, 2019)
- Form of promissory note issued to Oxford Finance LLC, dated May 3, 2019 (Filed With SEC on May 9, 2019)
- Form of Common Stock Certificate (Filed With SEC on May 9, 2019)
- Bridge Loan Note, dated March 13, 2018, by and among Alliqua BioMedical, Inc., AquaMed Technologies, Inc. and Perceptive Credit Holdings, LP (Filed With SEC on March 15, 2018)
- Amendment Agreement, dated March 13, 2018, by and among Alliqua BioMedical, Inc., AquaMed Technologies, Inc. and Perceptive Credit Holdings, LP (Filed With SEC on March 15, 2018)
- Forbearance and Amendment Agreement, dated February 5, 2018, by and among Alliqua BioMedical, Inc., AquaMed Technologies, Inc. and Perceptive Credit Holdings, LP (Filed With SEC on February 9, 2018)
- Asset Purchase Agreement, dated January 5, 2018, between Alliqua BioMedical, Inc. and Celularity Inc (Filed With SEC on January 5, 2018)
- Third Forbearance Agreement, dated November 7, 2017, by and between Alliqua BioMedical, Inc., Aquamed Technologies, Inc. and Perceptive Credit Holdings, L.P (Filed With SEC on November 9, 2017)
- Consent, Forbearance and Amendment Agreement, dated August 31, 2017, by and among Alliqua BioMedical, Inc., AquaMed Technologies, Inc., and Perceptive Credit Holdings, L.P (Filed With SEC on September 5, 2017)
- Asset Purchase Agreement, dated August 31, 2017, by and among Alliqua BioMedical, Inc. and Argentum Medical, LLC (Filed With SEC on September 5, 2017)
- SECOND FORBEARANCE AGREEMENT (Filed With SEC on August 10, 2017)
- AMENDMENT TO (1) CREDITAGREEMENT AND GUARANTY AND (2) WARRANT (Filed With SEC on June 5, 2017)
- AMENDMENT NO.2 TO FORBEARANCE AND AMENDMENTAGREEMENT (Filed With SEC on May 1, 2017)
- AMENDED WARRANT (Filed With SEC on April 12, 2017)
- COMMON STOCK PURCHASE WARRANT AlliquaBioMedical, Inc. (Filed With SEC on April 4, 2017)
- 9,473,250 Shares ALLIQUA BIOMEDICAL, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 31, 2017)
- AMENDED WARRANT (Filed With SEC on March 13, 2017)
- AMENDMENT NO.1 TO FORBEARANCE AND AMENDMENTAGREEMENT (Filed With SEC on March 13, 2017)
- AMENDED WARRANT (Filed With SEC on January 30, 2017)
- FORBEARANCE AND AMENDMENTAGREEMENT (Filed With SEC on January 30, 2017)
- PURCHASE AGREEMENT (Filed With SEC on August 9, 2016)
- WARRANT (Filed With SEC on June 1, 2015)
- PLEDGEAND SECURITY AGREEMENT (Filed With SEC on June 1, 2015)
- CREDIT AGREEMENT AND GUARANTY dated as of May 29, 2015 by and among ALLIQUA BIOMEDICAL, INC., as the Borrower, THE GUARANTORS PARTY HERETO, and PERCEPTIVE CREDIT OPPORTUNITIES... (Filed With SEC on June 1, 2015)
- 6,593,407 ALLIQUA BIOMEDICAL, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 30, 2015)
- WARRANT EXCHANGE AGREEMENT (Filed With SEC on May 6, 2014)
- STOCK PURCHASEAGREEMENT BY ANDBETWEEN CelgeneCORPORATION AND ALLIQUA,INC. NOVEMBER14, 2013 (Filed With SEC on March 24, 2014)
- ALLIQUA, INC. WARRANT (Filed With SEC on March 24, 2014)
- OPTION CANCELLATION AND RELEASE AGREEMENT (Filed With SEC on January 10, 2014)
- OPTION CANCELLATION AND RELEASE AGREEMENT (Filed With SEC on January 10, 2014)
- ALLIQUA, INC. NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on December 27, 2013)
